Erratum to: Endocrine DOI 10.1007/s12020-016-0939-0
In “Glucagon and insulin” section of the original publication, it was incorrectly described as “glucose showed a strong and rapid suppression of both LDLR and PCSK9 proteins”, instead of “glucagon showed a suppression of PCSK9 mRNA and protein levels”. It should be read as:
“Such observation was corroborated by a study reporting how rat administered with glucagon showed a suppression of PCSK9 mRNA and protein levels, as well as a 25 % reduction in SREBP-2 mRNA expression [50].”
Author information
Authors and Affiliations
Corresponding author
Additional information
The online version of the original article can be found under doi: 10.1007/s12020-016-0939-0.
Rights and permissions
About this article
Cite this article
Ferri, N., Ruscica, M. Erratum to: Proprotein convertase subtilisin/kexin type 9 (PCSK9) and metabolic syndrome: insights on insulin resistance, inflammation, and atherogenic dyslipidemia. Endocrine 54, 602 (2016). https://doi.org/10.1007/s12020-016-1109-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-016-1109-0